Search Within

Ross Levine

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (386)
  2. Meeting Abstract (343)
  3. Editorial (14)
  4. Review (13)
  5. Research Letter (10)
  6. Book Section (3)
  7. Conference Paper (2)
  8. Guidelines (2)
  9. Book Whole (1)
Groups
  1. Adult Leukemia (774)
  2. Center for Hematologic Malignancies (774)
  3. Department of Medicine (774)
  4. Executive Committee, Center for Hematologic Malignancies (774)
  5. GSK Faculty (774)
  6. Hematologic Malignancies, Division of (774)

More Groups

People
  1. Omar Abdel-Wahab (166)
  2. Martin Tallman (131)
  3. Raajit Rampal (87)
  4. Eytan Stein (69)
  5. Maria Arcila (60)
  6. Jay Patel (52)

More People

Years
  1. 2025 (5)
  2. 2024 (32)
  3. 2023 (46)
  4. 2022 (41)
  5. 2021 (44)
  6. 2020 (58)

More Years

Publications
  1. Blood (289)
  2. Leukemia (34)
  3. Cancer Research (27)
  4. Haematologica (24)
  5. Blood Advances (21)
  6. Cancer Cell (21)

More Publications

Publishers
  1. American Society of Hematology (312)
  2. Nature Publishing Group (107)
  3. American Association for Cancer Research (67)
  4. Cell Press (47)
  5. Ferrata Storti Foundation (24)
  6. American Society of Clinical Oncology (22)

More Publishers

Results (774)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Single-cell functional proteomics microchip for profiling circulating hematopoietic stem/progenitor cells and early detection of myelofibrosis
    Conference Paper

    Chen, J.; Kim, D.; Chen, Z.; Kleppe, M.; Levine, R.; Fan, R.
    Chemical and Biological Microsystems Society (2018)

    Fulltext@MSK | Save
  • Sphingolipid metabolism determines the efficacy of nanoliposomal ceramide in acute myeloid leukemia
    Meeting Abstract

    Annageldiyev, C.; Sharma, A.; Barth, B. M.; Fox, T. E.; Deering, T.; Devine, V.; Keasey, N. R.; Stern, S. T.; Young, M. M.; Wang, H. G. W.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • PHF6 mutations are mutually exclusive to TP53 mutations, and define a distinct subgroup of secondary acute myeloid leukemia associated with a primitive stem/progenitor immunophenotype, absent complex karyotype and relatively better outcomes
    Meeting Abstract

    Xiao, W.; Goldberg, A. D.; Ball, B.; Famulare, C.; Pastore, F.; Tallman, M. S.; Zhang, Y.; Arcila, M. E.; Papaemmanuil, E.; Levine, R. L.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Loss of plasmacytoid dendritic cell differentiation is highly predictive for persistent measurable residual disease and poor outcomes in acute myeloid leukemia
    Meeting Abstract

    Xiao, W.; Goldberg, A. D.; Famulare, C.; Delvin, S.; Patel, M.; McGovern, E.; Patel, A.; Schulman, J.; Dunbar, A.; Epstein-Peterson, Z. D.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • MLL-Menin inhibition reverses pre-leukemic progenitor self-renewal induced by NPM1 mutations and prevents AML development
    Meeting Abstract

    Uckelmann, H. J.; Kim, S. M.; Antonissen, N. J. C.; Krivtsov, A. V.; Hatton, C.; McGeehan, G. M.; Levine, R. L.; Vassiliou, G. S.; Armstrong, S. A.
    Blood (2018)

    Fulltext@MSK | Save
  • Early detection and molecular characterization of therapy-related leukemia in children reveals patterns of disease transformation and guides future surveillance protocols
    Meeting Abstract

    Spitzer, B.; Gundem, G.; Farnoud, N.; Millard, N.; McGovern, E.; Patel, M.; Levine, M.; Medina, J.; Zhou, Y.; Arango Ossa, J. E.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Enasidenib is highly active in previously untreated IDH2 mutant AML: Early results from the Beat AML Master Trial
    Meeting Abstract

    Stein, E. M.; Shoben, A.; Borate, U.; Baer, M. R.; Stock, W.; Patel, P. A.; Kovacsovics, T.; Blum, W.; Vergilio, J. A.; Heerema, N. A.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Prognostic impact of activating mutations of the NRAS/KRAS genes in patients with primary and post-essential thrombocythemia (ET)/polycythemia vera (PV) myelofibrosis (MF)
    Meeting Abstract

    Santos, F. P. S.; Getta, B.; Masarova, L.; Famulare, C.; Schulman, J.; Puga, R. D.; Paiva, R. D. A.; Hamerschlak, N.; Kantarjian, H. M.; Levine, R. L.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • A novel prognostic model including cytogenetic and molecular data in patients with primary and post-essential thrombocythemia (ET)/polycythemia vera (PV) myelofibrosis (MF)
    Meeting Abstract

    Santos, F. P. S.; Getta, B.; Masarova, L.; Famulare, C.; Schulman, J.; Datoguia, T. S.; Goncalves, G. A. R.; Hamerschlak, N.; Kantarjian, H. M.; Levine, R. L.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • A next-generation sequencing-based karyotyping algorithm reveals the genomic structure of acute myeloid leukemia
    Meeting Abstract

    Pavlick, D.; Montesion, M.; Heerema, N. A.; Severson, E. A.; Brennan, T.; Frampton, G. M.; He, J.; Byrd, J. C.; Levine, R. L.; Burd, A.; more...
    Blood (2018)

    Fulltext@MSK | Save